ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue105,555113,420103,37992,999
Cost of Revenue31,28027,36424,02721,053
Gross Profit74,27586,05679,35271,946
Operating Expenses
Research Development18,19018,78710,7328,290
Selling General and Administrative28,13621,54018,01314,825
Non Recurring----
Total Operating Expenses77,60667,69152,77244,168
Operating Income or Loss27,94945,72950,60748,831
Income from Continuing Operations
Total Other Income/Expenses Net-4,742473263-577
Earnings Before Interest and Taxes27,94945,72950,60748,831
Interest Expense----
Income Before Tax23,20746,20250,87048,254
Income Tax Expense4,48514,38618,32317,496
Minority Interest----
Net Income From Continuing Ops18,72231,81632,54730,758
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income18,72231,81632,54730,758
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares18,72231,81632,54730,758